Bioprocess Products Covering Your Entire Biomanufacturing
Bio-link's portfolio of offerings cover the entire upstream and downstream bioprocess such as cell culture, single-use mixing and storage, chromatography purification, filtration and ultrafiltration, as well as process development services.
Flexible and efficient single-use bioprocessing solutions including fluid management hardware and consumables.
Different types of bioreactors, cell bags and microcarriers.
Chromatography media, columns, prepacked columns and downstream purification solutions.
Bioprocess filtration hardware and consumables.
Bio-Link, Your Reliable Solution Provider in Bioprocessing
Biolink provides complete solutions for bioproducts manufacturing as antibodies, vaccines,recombinant protein, gene and cell therapies. We accelerate the rapid development of global biotechnology by providing reliable and efficient product portfolio and solutions.
Support from r&d to commercial scale to help your innovative therapy enter market quickly.
At Bio-Link, we link to enable biotechnologies.
Headquartered in Shanghai, Bio-Link is a loyal partner of biopharmaceutical companies and institutions. By providing advanced and reliable products and solutions, we are committed to continuously promoting the rapid development of biotechnology industries such as antibodies, vaccines, recombinant protein and advanced therapies.
Approach Professional Bioprocessing Services At Bio-Link
Our single-usebioprocessing andchromatography productfactories across the countryguarantee your continuousand stable production.
Over 1000 verificationdocuments including iso9001:2015 ensure your processes to be safe and compliant.
Our strong engineer team can meet various customization needs andprovide you with one-stop process support.
Professional after-salesupport that escorts your craftsmanship.
Quick response and efficientservice to maximize your business value.
What Obstacles Will Car-t Therapy Face in The Real World?
Based on the high efficacy of CAR-T cell therapy in clinical studies, it is gradually becoming a new choice for cancer patients. However, CAR-T prescriptions that should have grown with growth have been slow to increase. What is the reason that hinders the use of CAR-T in the real world?
News & Events
Exosome Downstream Process Solutions
In 2013, the Nobel Prize in Physiology or Medicine was awarded to American scientists James Rothman and Randy Schekman and German scientist Thomas Zudhof for their work in the field of regulating mech...